Skip to main content

Advertisement

Log in

Autologous Muscle-Derived Cells for Urinary Sphincter Regeneration: Where are we now?

  • Stress Incontinence and Prolapse (S Reynolds, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Stress urinary incontinence (SUI) remains a strikingly common condition faced by women with substantial economic and quality of life impact. Embarking upon treatment for incontinence often culminates with invasive surgical procedures with recognized complication profiles. Innovative directions for SUI therapeutics are on the horizon, including the utilization of adult autologous muscle-derived cells for urinary sphincter regeneration (AMDC-USR).

Recent Findings

Current published literature presents safety and efficacy data regarding AMDC-USR injection in 80 patients at 12-month follow-up. No adverse events attributed to the cellular product were reported. Compared to lower dose groups, the higher dose groups demonstrated enhanced percentages of patients with at least 50% reduction in stress leaks and pad weight at 12-month follow-up. All dose groups had statistically significant improvement in patient-reported incontinence-specific quality of life scores at 12-month follow-up. Conclusions from the pooled analyses indicate that injection of AMDC-USR across a range of dosages appears safe. Efficacy data suggests a dose response with more patients responsive to the higher doses of AMDC-USR.

Summary

Promising technologies for utilization of autologous cellular therapies for treatment of SUI, and conceivably multiple additional indications, are approaching fruition. Multiple phase III randomized, placebo-controlled studies for AMDC-USR are ongoing to bring this regenerative option forth for the millions of patients who may ultimately benefit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major Importance

  1. • Reynolds WS, Dmochowski RR, Penson DF. Epidemiology of stress urinary incontinence in women. Current Urology Reports. 2011;12(5):370–6. Historically significant manuscript detailing current concepts of SUI etiology.

    Article  Google Scholar 

  2. Petros PE, Woodman PJ. The integral theory of continence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(1):35–40.

    Article  Google Scholar 

  3. Gill BC, Damaser MS, Vasavada SP, Goldman HB. Stress incontinence in the era of regenerative medicine: reviewing the importance of the pudendal nerve. J Urol. 2013;190(1):22–8.

    Article  Google Scholar 

  4. •• Thompson IM, Kaufman MR. Nonsurgical interventions for incontinence: where is the evidence? Curr Blad Dysfn Rep. 2010;5(3):163–7. Critical guidelines for utilization of surgical therapies for SUI.

    Article  Google Scholar 

  5. Kobashi KC, Albo ME, Dmochowski RR, Ginsberg DA, Goldman HB, Gomelsky A, et al. Surgical treatment of female stress urinary incontinence: AUA/SUFU guideline. J Urol. 2017;198(4):875–83.

    Article  Google Scholar 

  6. Wood LN, Anger JT. Urinary incontinence in women. BMJ. 2014;349:g4531.

    Article  Google Scholar 

  7. SUFU. http://sufuorg.com/docs/news/augs-sufu-mus-position-statement.aspx.

  8. Koski ME, Chamberlain J, Rosoff J, Vaughan T, Kaufman MR, Winters JC, et al. Patient perception of transvaginal mesh and the media. Urology. 2014;84(3):575–82.

    Article  Google Scholar 

  9. Athanasopoulos A, Gyftopoulos K, McGuire EJ. Efficacy and preoperative prognostic factors of autologous fascia rectus sling for treatment of female stress urinary incontinence. Urology. 2011;78(5):1034–8.

    Article  Google Scholar 

  10. Williams JK, Dean A, Badlani G, Andersson KE. Regenerative medicine therapies for stress urinary incontinence. J Urol. 2016;196(6):1619–26.

    Article  Google Scholar 

  11. Hwang K, Lewis S, Lamb DJ. Stem cell research: implications for urology. AUA Update Series. 2010;29(8):77–84.

    Google Scholar 

  12. Vinarov A, Atala A, Yoo J, Slusarenco R, Zhumataev M, Zhito A, et al. Cell therapy for stress urinary incontinence: present-day frontiers. J Tissue Eng Regen Med. 2018;12(2):e1108–e21.

    Article  CAS  Google Scholar 

  13. Wang HJ, Chuang YC, Chancellor MB. Development of cellular therapy for the treatment of stress urinary incontinence. Int Urogynecol J. 2011;22(9):1075–83.

    Article  CAS  Google Scholar 

  14. Chancellor MB, Yokoyama T, Tirney S, Mattes CE, Ozawa H, Yoshimura N, et al. Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility. Neurourol Urodyn. 2000;19(3):279–87.

    Article  CAS  Google Scholar 

  15. Yokoyama T, Yoshimura N, Dhir R, Qu Z, Fraser MO, Kumon H, et al. Persistence and survival of autologous muscle derived cells versus bovine collagen as potential treatment of stress urinary incontinence. J Urol. 2001;165(1):271–6.

    Article  CAS  Google Scholar 

  16. Furuta A, Jankowski RJ, Pruchnic R, Yoshimura N, Chancellor MB. The promise of stem cell therapy to restore urethral sphincter function. Curr Urol Rep. 2007;8(5):373–8.

    Article  Google Scholar 

  17. Kwon D, Kim Y, Pruchnic R, Jankowski R, Usiene I, de Miguel F, et al. Periurethral cellular injection: comparison of muscle-derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of stress urinary incontinence. Urology. 2006;68(2):449–54.

    Article  Google Scholar 

  18. Yiou R, Yoo JJ, Atala A. Restoration of functional motor units in a rat model of sphincter injury by muscle precursor cell autografts. Transplantation. 2003;76(7):1053–60.

    Article  Google Scholar 

  19. Yokoyama T, Pruchnic R, Lee JY, Chuang YC, Jumon H, Yoshimura N, et al. Autologous primary muscle-derived cells transfer into the lower urinary tract. Tissue Eng. 2001;7(4):395–404.

    Article  CAS  Google Scholar 

  20. Chermansky CJ, Tarin T, Kwon DD, Jankowski RJ, Cannon TW, de Groat WC, et al. Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency. Urology. 2004;63(4):780–5.

    Article  Google Scholar 

  21. Cannon TW, Lee JY, Somogyi G, Pruchnic R, Smith CP, Huard J, et al. Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra. Urology. 2003;62(5):958–63.

    Article  Google Scholar 

  22. Lee JY, Cannon TW, Pruchnic R, Fraser MO, Huard J, Chancellor MB. The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2003;14(1):31–37; discussion 7.

  23. Kleinert S, Horton R. Retraction--autologous myoblasts and fibroblasts versus collagen [corrected] for treatment of stress urinary incontinence in women: a [corrected] randomised controlled trial. Lancet. 2008;372(9641):789–90.

    Article  Google Scholar 

  24. Carr LK, Steele D, Steele S, Wagner D, Pruchnic R, Jankowski R, et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(6):881–3.

    Article  CAS  Google Scholar 

  25. • Carr LK, Robert M, Kultgen PL, Herschorn S, Birch C, Murphy M, et al. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study. J Urol. 2013;189(2):595–601. Pooled data from phase I/II studies on safety and efficacy of AMDS-USR.

    Article  Google Scholar 

  26. Peters KM, Dmochowski RR, Carr LK, Robert M, Kaufman MR, Sirls LT, et al. Autologous muscle derived cells for treatment of stress urinary incontinence in women. J Urol. 2014;192(2):469–76.

    Article  Google Scholar 

  27. Carr L, Tu LM, Robert M, Quinlan D, Carlson K, Herschorn S, Dmochowski R, Peters K, Kaufman M, Jankowski R, Chancellor M. Autologous muscle derived cells for urinary sphincter repair for recurrent or persistent stress urinary incontinence after continence surgery. AUA Annual Meeting; 2017; Boston.

  28. Pruchnic R, Jankowski R and Kaufman MR. Lessons learned from a multicenter, randomized, double-blind, placebo controlled study of autologous muscle derived cells for urinary sphincter repair. International Continence Society Annual Meeting. 2017; Florence, Italy.

  29. Quinlan D, Carr L, Tu LM, Robert M, Carlson K, Herschorn S, Dmochowski R, Peters K, Kaufman M, Jankowski R and Chancellor M. Autologous muscle derived cells for urinary sphincter repair for recurrent or persistent stress urinary incontinence after continence surgery. IUGA. 2017; Vancouver, Canada.

  30. Blaganje M, Lukanovic A. Intrasphincteric autologous myoblast injections with electrical stimulation for stress urinary incontinence. Int J Gynaecol Obstet. 2012;117(2):164–7.

    Article  Google Scholar 

  31. Blaganje M, Lukanovic A. Ultrasound-guided autologous myoblast injections into the extrinsic urethral sphincter: tissue engineering for the treatment of stress urinary incontinence. Int Urogynecol J. 2013;24(4):533–5.

    Article  Google Scholar 

  32. Sebe P, Doucet C, Cornu JN, Ciofu C, Costa P, de Medina SG, et al. Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study. Int Urogynecol J. 2011;22(2):183–9.

    Article  Google Scholar 

  33. Elmi A, Kajbafzadeh AM, Tourchi A, Talab SS, Esfahani SA. Safety, efficacy and health related quality of life of autologous myoblast transplantation for treatment of urinary incontinence in children with bladder exstrophy-epispadias complex. J Urol. 2011;186(5):2021–6.

    Article  Google Scholar 

  34. Stangel-Wojcikiewicz K, Jarocha D, Piwowar M, Jach R, Uhl T, Basta A, et al. Autologous muscle-derived cells for the treatment of female stress urinary incontinence: a 2-year follow-up of a Polish investigation. Neurourol Urodyn. 2014;33(3):324–30.

    Article  Google Scholar 

  35. Gras S, Klarskov N, Lose G. Intraurethral injection of autologous minced skeletal muscle: a simple surgical treatment for stress urinary incontinence. J Urol. 2014;192(3):850–5.

    Article  Google Scholar 

  36. Gerullis H, Eimer C, Georgas E, Homburger M, El-Baz AG, Wishahi M, et al. Muscle-derived cells for treatment of iatrogenic sphincter damage and urinary incontinence in men. ScientificWorldJournal. 2012;2012:898535.

    Article  CAS  Google Scholar 

  37. Levanovich PE, Diokno A, Hasenau DL, Lajiness M, Pruchnic R, Chancellor MB. Intradetrusor injection of adult muscle-derived cells for the treatment of underactive bladder: pilot study. Int Urol Nephrol. 2015;47(3):465–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Melissa R. Kaufman.

Ethics declarations

Conflict of Interest

Dr. Kaufman serves as the Global Principal Investigator for Cook Myosite.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Stress Incontinence and Prolapse

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaufman, M.R. Autologous Muscle-Derived Cells for Urinary Sphincter Regeneration: Where are we now?. Curr Bladder Dysfunct Rep 13, 252–256 (2018). https://doi.org/10.1007/s11884-018-0486-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-018-0486-z

Keywords

Navigation